Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-ne...
Dr Iris Nederlof - The Netherlands Cancer Institute, Amsterdam, Netherlands
Nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast cancer ( Dr Iris Nederlof - The Netherlands Cancer Institute, Amsterdam, Netherlands )
12 Sep 2022
Atezolizumab improves on single-agent chemo for NSCLC not eligible for platinum-...
Prof Siow-Ming Lee - University College London, London, UK
Atezolizumab improves on single-agent chemo for NSCLC not eligible for platinum-containing regimen ( Prof Siow-Ming Lee - University College London, London, UK )
12 Sep 2022
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in ...
Prof Siow-Ming Lee - University College London, London, UK
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in pts with NSCLC ( Prof Siow-Ming Lee - University College London, London, UK )
12 Sep 2022
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy...
Prof Chris Parker - Institute of Cancer Research, Sutton, UK
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prostate cancer ( Prof Chris Parker - Institute of Cancer Research, Sutton, UK )
12 Sep 2022
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer
Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike Schlürma...
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer ( Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike Schlürmann )
11 Sep 2022
A new era of early cancer detection with blood test may change cancer screening ...
Dr Deb Schrag, Memorial Sloan Kettering Cancer Center, New York, USA
A new era of early cancer detection with blood test may change cancer screening paradigms ( Dr Deb Schrag, Memorial Sloan Kettering Cancer Center, New York, USA )
11 Sep 2022
Metastatic breast cancer endpoints for survival: rwPFS and TTNT
Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA
Metastatic breast cancer endpoints for survival: rwPFS and TTNT ( Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA )
10 Sep 2022
New data presented at ESMO for multi-cancer early detection
Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences
New data presented at ESMO for multi-cancer early detection ( Dr Tom Beer - Vice President and Chief Medical Officer of Exact Sciences )
10 Sep 2022
Scientists discover mechanism of action and an actionable inflammatory axis for ...
Prof Charles Swanton - The Francis Crick Institute, London, UK
Scientists discover mechanism of action and an actionable inflammatory axis for air pollution induced NSCLC ( Prof Charles Swanton - The Francis Crick Institute, London, UK )
10 Sep 2022
Nirogacestat success for desmoid tumours
Dr Bernd Kasper - Universitätsmedizin Mannheim, Mannheim, Germany
Nirogacestat success for desmoid tumours ( Dr Bernd Kasper -  Universitätsmedizin Mannheim, Mannheim, Germany )
10 Sep 2022
Cervical cancer programme in Kenya: lessons to guide elimination as a public hea...
Dr Valerian Mwenda - Ministry of Health, Nairobi, Kenya
Cervical cancer programme in Kenya: lessons to guide elimination as a public health problem ( Dr Valerian Mwenda - Ministry of Health, Nairobi, Kenya )
25 Aug 2022
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
22 Aug 2022